These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 28806036)
41. Off-label prescribing patterns of antidepressants in children and adolescents. Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674 [TBL] [Abstract][Full Text] [Related]
42. Fluoroquinolones and peripheral neuropathy. Med Lett Drugs Ther; 2013 Nov; 55(1429):89. PubMed ID: 24220576 [No Abstract] [Full Text] [Related]
43. Identification of potential drug name confusion errors in the Sentinel System. Cocoros NM; Haynes K; Her Q; Cosgrove A; Dee E; Lin ND; Tu CM; Ding Y; Nguyen M; Toh S Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1405-1410. PubMed ID: 31483085 [TBL] [Abstract][Full Text] [Related]
44. Regulating off-label drug use--rethinking the role of the FDA. Stafford RS N Engl J Med; 2008 Apr; 358(14):1427-9. PubMed ID: 18385495 [No Abstract] [Full Text] [Related]
45. Off-label prescribing. Legal implications. Henry V J Leg Med; 1999 Sep; 20(3):365-83. PubMed ID: 10530051 [No Abstract] [Full Text] [Related]
47. Off-label prescribing to children in the United States outpatient setting. Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098 [TBL] [Abstract][Full Text] [Related]
48. Impact of FDA Black Box Warning on Psychotropic Drug Use in Noninstitutionalized Elderly Patients Diagnosed With Dementia: A Retrospective Study. Singh RR; Nayak R J Pharm Pract; 2016 Oct; 29(5):495-502. PubMed ID: 25917167 [TBL] [Abstract][Full Text] [Related]
51. Fluoroquinolone-induced generalized fixed drug eruption. Hager JL; Mir MR; Hsu S Dermatol Online J; 2009 Dec; 15(12):8. PubMed ID: 20040258 [No Abstract] [Full Text] [Related]
52. Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight. Yang J; Xie RH; Krewski D; Wang YJ; Walker M; Wen SW Int J Infect Dis; 2011 May; 15(5):e336-41. PubMed ID: 21345707 [TBL] [Abstract][Full Text] [Related]
53. Advisory committees tell FDA-CVM: restrict fluoroquinolone uses in food-producing animals. Gloyd JS J Am Vet Med Assoc; 1994 Jul; 205(1):19-20. PubMed ID: 7928541 [No Abstract] [Full Text] [Related]
54. Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk. Li C; Mercuro NJ; Chapin RW; Gold HS; McCoy C Antimicrob Agents Chemother; 2021 Aug; 65(9):e0070821. PubMed ID: 34181481 [TBL] [Abstract][Full Text] [Related]
57. New drugs: golimumab, besifloxacin hydrochloride, and artemether/lumefantrine. Hussar DA J Am Pharm Assoc (2003); 2009; 49(4):570-4. PubMed ID: 19589772 [No Abstract] [Full Text] [Related]
58. Rooting out institutional corruption to manage inappropriate off-label drug use. Rodwin MA J Law Med Ethics; 2013; 41(3):654-64. PubMed ID: 24088156 [TBL] [Abstract][Full Text] [Related]
59. Impact of recent black box warnings in the allergy world. Oppenheimer J; Aaronson D Ann Allergy Asthma Immunol; 2007 Oct; 99(4):364-6. PubMed ID: 17941285 [No Abstract] [Full Text] [Related]
60. [Focus on fluoroquinolones safety]. Liu ZY; Wang AX Zhonghua Nei Ke Za Zhi; 2009 Apr; 48(4):271-3. PubMed ID: 19576111 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]